Last reviewed · How we verify

NCT04988451: FASL

Family ASL: Longitudinal Study of Deaf Children and Hearing Parents Who Receive Services to Support the Learning of ASL

Active, enrolled NA Last updated 11 July 2025
What this trial tests

NA trial testing ASL Services in Deafness in 40 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
20 July 2021
Primary endpoint
30 November 2025
30 November 2025

Quick facts

Lead sponsorUniversity of Connecticut
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationnon randomized
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment40
Start date20 July 2021
Primary completion30 November 2025
Estimated completion30 November 2025
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Connecticut

Who can join

2 and older, any sex, with Deafness or Hearing Loss. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study examines the development of American Sign Language by deaf and hard of hearing (DHH) children and their parents.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Deafness

Currently open trials in the same condition.

Other University of Connecticut trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04988451.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing